The release of pro-inflammatory chemokines and cytokines, such as IL-1, IL-2, IL-6, CCL-2, CCL-8, TNF-α and TGF-β, facilitate the recruitment of brain-resident immune cells to the tumour site [64]. The gene discussed is IL2; the disease is neoplasm.